|
Lance R. Peterson, MD, FASCP, FIDSA, FAAM, is the Director of Microbiology and Infectious Diseases Research, and associate Epidemiologist at Evanston Northwestern Healthcare, in Evanston Illinois. He is also Professor of Pathology and Medicine at Northwestern University’s Feinberg School of Medicine in Chicago, and a staff member in the Clinical Microbiology and Infectious Disease Divisions at Evanston Hospital. After receiving a Bachelor of Science degree from the University of Minnesota in Minneapolis in 1971, Dr. Peterson was awarded a Doctor of Medicine degree from the University of Minnesota in 1972. He then completed an internship at St. Paul-Ramsey Medical Center, a residency in Internal Medicine at the University of Minnesota Hospitals, and a fellowship in Infectious Diseases at the VA Medical Center, all in the Twin Cities of Minnesota. He has directed the clinical microbiology laboratories at the Minneapolis VA Medical Center and Northwestern Memorial Hospital in Chicago. At both medical centers he was also a consultant in Infectious Diseases. In 1998 he became the first director of the Northwestern Prevention Epicenter, a CDC network of academic hospitals implemented to develop strategies for preventing healthcare-associated infections and reducing infectious diseases caused by drug-resistant bacteria. He was elected to the Best Doctors in America in 1996, and joined Evanston Northwestern Healthcare in 2002. Dr. Peterson is a Diplomate of the American Board of Internal Medicine, the Subspecialty of Infectious Diseases, and the Special Competency in Medical Microbiology examinations. He is a fellow of the Infectious Diseases Society of America, the American Society for Clinical Pathology, and the American Academy of Microbiology, as well as a member of the American Society for Microbiology, the British Society for Antimicrobial Chemotherapy, and Secretary/Treasurer of the Chicago Area Infectious Diseases Society. His research interests have included the study of infections in the extremities of diabetic patients; investigations of antimicrobial agents in models that simulate closed space, neutropenic infections; the epidemiology of nosocomial pathogens (particularly MRSA, enterococci, and Clostridium difficile); the development and evaluation of molecular diagnostic testing; measuring activity of new compounds against bacteria and fungi; and the study of the molecular mechanisms for the resistance of staphylococci and pneumococci to the new fluoroquinolone antimicrobial agents. Current research activities focus on using molecular testing methods to enhance infection control activities; understanding the regulation of antimicrobial agent resistance in staphylococci and Enterobacteriaceae; designing novel strategies for treatment of infections due to resistant bacteria; and developing new diagnostic tests for rapidly detecting microbial pathogens. He has over 500 scientific publications/ presentations and is recognized in the 21st Century editions of Marquis' Who's Who.
|
Lance R. Peterson, MD, Director, Clinical Microbiology and Infectious Diseases Research Division, NorthShore University Health system